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ABSTRACT
Background Globally, critical illness results in millions 
of deaths every year. Although many of these deaths 
are potentially preventable, the basic, life- saving care of 
critically ill patients are often overlooked in health systems. 
Essential Emergency and Critical Care (EECC) has been 
devised as the care that should be provided to all critically 
ill patients in all hospitals in the world. EECC includes 
the effective care of low cost and low complexity for the 
identification and treatment of critically ill patients across 
all medical specialties. This study aimed to specify the 
content of EECC and additionally, given the surge of critical 
illness in the ongoing pandemic, the essential diagnosis- 
specific care for critically ill patients with COVID-19.
Methods In a Delphi process, consensus (>90% 
agreement) was sought from a diverse panel of global 
clinical experts. The panel iteratively rated proposed 
treatments and actions based on previous guidelines and 
the WHO/ICRC’s Basic Emergency Care. The output from 
the Delphi was adapted iteratively with specialist reviewers 
into a coherent and feasible package of clinical processes 
plus a list of hospital readiness requirements.
Results The 269 experts in the Delphi panel had clinical 
experience in different acute medical specialties from 
59 countries and from all resource settings. The agreed 
EECC package contains 40 clinical processes and 67 
requirements, plus additions specific for COVID-19.
Conclusion The study has specified the content of 
care that should be provided to all critically ill patients. 
Implementing EECC could be an effective strategy for 
policy makers to reduce preventable deaths worldwide.
INTRODUCTION
Critical illness, when defined as a state of 
ill health with vital organ dysfunction and 
a high risk of imminent death, is common 
in hospitals throughout the world.1–6 It is 
the most severe form of acute illness due 
to any underlying condition and results in 
millions of deaths globally every year.1 5 The 
COVID-19 pandemic has led to increased 
morbidity and mortality with a surge in crit-
ical illness worldwide.7–9
Many of the deaths due to critical illness 
are potentially preventable.10–12 In crit-
ical illness, the patient’s airway, breathing 
or circulation may become compromised, 
and early identification of the problem and 
timely care can be lifesaving. Unfortunately, 
this care is frequently a neglected part of 
healthcare. The basic, life- saving clinical 
processes may be overlooked in specialised 
care12 and in settings of both high13–15 and 
low resources.16–18 In hospitals all over the 
world, guidelines, equipment and routines 
focusing on the care of critically ill patients, 
are often missing for adult19 and paediatric 
Key questions
What is already known?
 ► Critical illness is common throughout the world and 
COVID-19 has caused a global surge of critically ill 
patients.
 ► There are large gaps in the quality of care for crit-
ically ill patients, especially in low- staffed and low- 
resourced settings, and mortality rates are high.
 ► Essential Emergency and Critical Care (EECC) is 
the effective lifesaving care of low- cost and low- 
complexity that all critically ill patients should re-
ceive in all wards in all hospitals in the world.
What are the new findings?
 ► The clinical processes that comprise EECC and the 
essential care of critically ill patients with COVID-19 
have been specified in a large consensus among 
clinical experts worldwide.
 ► The resource requirements for hospitals to be ready 
to provide this care has been described.
What do the new findings imply?
 ► The findings can be used across medical specialties 
in hospitals worldwide to prioritise and implement 
essential care for reducing preventable deaths.
 ► Inclusion of the EEEC processes could increase the 
impact of pandemic preparedness and response 
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patients,11 in emergency units,20 in wards21 and in 
intensive care units.22 Improving the way healthcare 
manages critical illness could save many lives.11 23 24
To improve outcomes for critically ill patients by 
means that are feasible to deliver in all hospital wards 
and settings, the Essential Emergency and Critical Care 
(EECC) concept was devised.25 EECC is defined as the 
care that should be provided to all critically ill patients 
of all ages in all hospitals in the world. It is distin-
guished by three principles. First, priority to those with 
the most urgent clinical need, including both early 
identification and timely care. Second, provision of the 
life- saving treatments that support and stabilise failing 
vital organ functions. And third, a focus on effective 
care of low cost and low complexity.
The clinical processes that comprise the essential care 
of critically ill patients, and the resources required for 
those processes have not previously been specified. As 
critically ill patients can be suffering from any under-
lying condition, EECC is conceptualised to be inte-
grated into all acute clinical specialties. We therefore 
sought consensus among a diverse group of global clin-
ical experts with the aim of specifying the content of 
EECC. An additional aim, given the ongoing pandemic, 
was consensus around the essential diagnosis- specific 
care for critically ill patients with COVID-19.
METHODS
The study used three phases (figure 1). First, a 
consensus was sought about the treatments and 
actions (T&A) in EECC using a modified Delphi 
technique.26 Second, the output from the Delphi was 
adjusted into a coherent, user- friendly and feasible 
package of clinical processes. And third, a list of 
requirements for hospitals to be ready to provide the 
care was developed.
Phase I
An online, three- round modified Delphi process 
was conducted in November and December 2020. 
The Delphi method uses anonymous responses from 
an expert panel to iteratively posed questions and 
controlled feedback to reach consensus on the topic 
of interest.26 A Delphi process was chosen for this 
study as EECC is new, its content has not been previ-
ously specified and a large group of diverse experts 
was required.
To be part of the panel, experts needed to have clin-
ical experience of caring for critically ill patients. To 
ensure the involvement of a diverse range of experts, 
it was decided that at least 50% of the invitations to 
participate in the panel should be sent to experts 
with substantial experience working in low- income 
and middle- income countries, and there should be a 
balance between clinical experience (work in general 
wards, emergency units, intensive care units); specialty 
(paediatrics, obstetrics, medicine, surgery, intensive 
care, anaesthesia and emergency care); profession 
(doctors, nurses, other health professionals); loca-
tion and gender. A list of potential participants was 
Figure 1 The study process. EECC, Essential Emergency and Critical Care; T&A, Treatment and actions.
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made from a mapping of stakeholders, the literature 
across all acute medical specialties, the researchers’ 
networks and additional purposive and snowball 
sampling for under- represented groups. Addition-
ally, a link to a screening survey was sent to global 
professional networks, specialist societies and on 
social media to identify further potential participants. 
A total of 895 experts were invited to participate, 
and those who accepted provided written informed 
consent.
EECC consists of clinical processes of care. To 
enable rating by the Delphi panel, clinical processes 
were disassembled into individual T&A. The T&A 
concern the identification of critical illness; care 
of critical illness, and the diagnosis- specific care of 
critically ill patients with COVID-19. To be included, 
all T&A were required to meet two a priori defined 
criteria: effectivenessi and feasibility.i Additionally, univer-
salityi was required for the identification and care 
of critical illness and relevancei was required for the 
diagnosis- specific care of critically ill patients with 
COVID-19. A draft list of potential T&A was devel-
oped based on clinical guidelines and tools from 
related specialties27–38 and aligned with the WHO/
International Committee of the Red Cross’s (ICRC) 
Basic Emergency Care.39 The draft list was revised 
by specialist reviewers—a group of senior clini-
cians, researchers and policy makers, with exper-
tise in paediatrics, medicine, emergency medicine, 
anaesthesia and intensive care, critical care nursing, 
obstetrics and gynaecology, and surgery.
Three Delphi rounds were deemed sufficient to address 
the aim while avoiding attrition and poor response rates. 
A 4- point Likert scale (strongly disagree, disagree, agree, 
strongly agree) with a ‘do- not know’ option was used for 
the panel to rate their opinion about the inclusion of 
each T&A in EECC.40–42 Consensus was achieved when 
more than 90% of respondents selected ‘agree’ or 
‘strongly agree’, excluding ‘don’t know’ responses. 
The experts were able to provide free- text comments, 
which were analysed to identify appropriate, relevant 
changes to the wording of T&A for clarity of under-
standing, and to identify newly proposed T&A. After 
the first round, newly proposed T&A that fulfilled 
the EECC criteria for potential inclusion were revised 
after input from the specialist reviewers and included 
for assessment by the panel. T&A that did not reach 
consensus in the previous round were presented for 
i Effectiveness: established or proven to be safe and to reduce mortality 
(compression to stop bleeding is effective; treating with leech therapy 
is not). Feasibility: low- cost and low complexity. Possible to provide in a 
low- staffed, low- resourced setting without the immediate presence of 
a doctor (placing a comatose patient in the recovery position (lateral 
position) is feasible; continuous haemodialysis is not). Universality: 
supports vital organ function rather than being the definitive care of 
a diagnosis (intravenous fluids for shock are universal; thrombolytic 
therapy is not). Relevance: established or proven to be a treatment for 
COVID-19.
reassessment in rounds two and three, together with 
a visual representation of the spread of previous 
responses.
As the Delphi panel was diverse, it was considered that 
there may be different opinions about the inclusion of 
T&As between experts with particular a priori defined 
characteristics. These subgroups of experts were those 
with work experience in a low- income country or not; 
those who are doctors or not; those with clinical experi-
ence in emergency care and those without; and those with 
clinical experience in intensive care and those without. 
The levels of agreement in each subgroup were assessed 
and presented for all the T&As that reached consensus.









  High- income country 139 52
  Middle- income country 115 43
  Low- income country 177 66
  Do not know 2 1
Clinical setting*
  General ward 153 57
  Emergency unit 179 67
  High dependency unit 153 57
  Intensive care unit 232 86
  Operating theatre 102 38
  Other 15 6
Specialty*
  Emergency care 93 35
  Intensive care 190 71
  Anaesthesia 59 22
  Medicine 39 15
  Surgery 20 7
  Paediatrics 47 17
  Obstetrics/gynaecology 13 5
  Other 25 9
Profession*
  Doctor 212 79
  Nurse 40 15
  Midwife 6 2
  Clinical officer 9 3
  Other 17 6
Gender*
  Female 102 38
  Male 165 62
*As the experts were asked to select all that apply, the sum of 
the percentages may exceed 100.
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Phase II
After the Delphi, slight adjustments were made to the 
wording of the T&A that had reached consensus to 
ensure language consistency. The T&A were reassem-
bled back into clinical processes to increase overall 
coherence and feasibility of the EECC package, with 
the goal of user- friendliness for health system imple-
mentation and quality improvement work. The adjust-
ments were done in an iterative process with the same 
specialist reviewers as in Phase I to ensure relevance 
for all acute medical specialties. The final package of 
clinical processes was organised into those relevant for 
identification, for care and general processes.
Phase III
A provisional list of hospital readiness requirements 
for the provision of the clinical processes were devel-
oped using existing WHO tools, guidelines for related 
specialties, facility preparedness lists29 32 34 35 37–39 43 44 
and the experience and knowledge of the study team. 
The specialist reviewers provided iterative input into the 
provisional list, approving suggested items, adding rele-
vant items from their clinical specialties and suggesting 
modifications. Based on previous work and following 
consultation with health economists and procurement 
experts, the final list of requirements was agreed and 
arranged into eight categories: equipment, consuma-
bles, drugs, human resources, training, routines, guide-
lines and infrastructure.
Patient and public involvement
Patients and the public were not involved in the design 
and conduct of the research.
RESULTS
Phase I
Of the 895 invited experts, 269 participated in the first 
round of the Delphi when the majority of the deci-
sions were made (30% response rate). In round 2, 228 
experts participated (85% of those in round 1) and 
round 3 included 194 experts (85% of those in round 
2). The panel comprised experts from diverse resource 
settings, clinical settings, specialties and professions 
(table 1). The panel included experts from 59 coun-
tries (figure 2) and 38% were female.
Of the 57 T&A for EECC in round 1, consensus was 
reached for 49. In round 2, 29 newly proposed T&A were 
added to the eight remaining from round 1, of which two 
had been reworded for clarity. Out of these 37, consensus 
was reached for 17. The remaining 20, of which another 
two had been reworded for clarity, were included in 
round 3. Consensus was reached for nine of the final 20 
T&A. In total, consensus was reached for 75 out of 86 
proposed T&A, including 54 of the original 57 (online 
supplemental table 1).
Of the seven T&A for the essential diagnosis- specific 
care of critically ill COVID-19 in round 1, all reached 
consensus for inclusion. In round 2, two newly proposed 
T&A were added. Neither of these reached consensus in 
round 2 or round 3.
Analyses of participant subgroups did not reveal 
substantial divergence from the overall results. For the 
T&A that reached 90% agreement in the panel, agree-
ment was not below 80% in any subgroup (online supple-
mental tables 2–4).
Phase II and III
After the Delphi, the T&A that had reached consensus 
were reassembled into a final user- friendly and feasible 
Figure 2 The expert panel locations. Created with mapchart.net. Disclaimer: the depictions of boundaries are not warranted 
to be error free.
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package of EECC containing 40 clinical processes—30 
identification and care processes and 10 general 
processes (table 2). All T&A for the care of critical 
illness were included, with some rewording and reor-
dering. Eleven T&A for the identification of critical 
illness were not included, so that the package could be 
feasible for triage in all hospitals, and were added as 
an addendum (outside the remit of EECC), in order 
to underscore their importance in settings where staff 
have sufficient time and expertise.
The list of hospital readiness requirements for EECC 
contained 67 items, (14 for identification and 53 for 
essential care) (table 3).
The essential diagnosis- specific care of critically ill 
patients with COVID-19 consisted of an additional seven 
clinical processes and nine hospital readiness require-
ments (table 4).
DISCUSSION
We have specified the content of EECC based on 
consensus among global clinical experts. While the 
EECC approach is new, the included clinical processes 
are commonly used in the care of sick patients and 
can be seen in WHO publications and specialist 
society standards and guidelines.29 32–35 38 39 45 The 
contribution of this study is the specification of a 
baseline bundle of care interventions that should be 
provided when needed to all critically ill patients in 
all hospitals in the world. This marks a break from 
previous guidelines that tend to be specialty- specific, 
condition- specific or location- specific, or that specify 
care that may be too complex and costly to provide in 
all hospital settings.
The EECC approach
EECC is an approach that supports priority- setting 
in health systems. In this regard, it has parallels to 
the approaches used in the WHO’s Essential Medi-
cines List,37 Interagency Integrated Triage Tool,29 
Emergency Triage and Treatment for Children32 
and Universal Health Coverage.36 EECC emphasises 
the identification and care of the critically ill, and 
the provision of the life- saving supportive care that 
is of low cost and of low complexity.25 EECC can be 
seen as a unifying concept for such aspects of patient 
management found in WHO and specialist guide-
lines, triage, early warning systems and rapid response 
teams.28 29 39 46 47 To maintain focus on life- saving 
supportive care and to be useful across all specialties, 
EECC does not include the definitive care of the under-
lying diagnoses. Instead, EECC is intended to comple-
ment specialty- based care and existing guidelines and 
does not aim to include all the care a patient needs—
as well as EECC, patients should receive diagnostics, 
definitive and symptomatic care of their condition, 
additional nursing care, and if available, higher levels 
of emergency and critical care. EECC seeks to bridge 
the quality gap that is commonly found between 
the current care of critical illness and best- practice 
guidelines.12 48 49 To ensure feasibility in settings with 
restricted human resources, EECC is designed to 
enable task- sharing between health professionals.50 
It should be noted that not all the EECC clinical 
processes will be needed in the care of every critically 
ill patient—they should be seen as essential ‘tools in 
the tool- box’ for health workers to use when required. 
To operationalise the EECC approach, it is intended 
that the content specified here is used to develop tools 
for quality monitoring, teaching and integration into 
other guidelines and recommendations.
EECC complements the current healthcare organisation
The basic clinical processes specified in EECC have 
been overlooked in healthcare.11 13–15 18 20 51 52 In UK 
hospitals, half of the patients received substandard 
basic vital organ support prior to intensive care and 
31% of preventable deaths were associated with absent 
clinical monitoring.13 14 In Malawi, 89% of adult 
hypoxic patients and 75% of children dying from 
pneumonia in hospital did not receive oxygen.17 18 
The usual organisational set- up of health services may 
be one underlying reason for this. Specialist units 
with a primary function of delivering the defini-
tive management for one disease group may under- 
estimate the effort needed to maintain core processes 
and competences in the supportive management of 
critically ill patients. Innovative and specialised treat-
ments and technologies may become preferred to 
those that are basic and long- standing.53 By targeting 
a feasible, lowest baseline quality for critically ill 
patients throughout hospital settings, EECC provides 
a complimentary approach to the current organisa-
tion that safeguards the provision of basic life- saving 
actions, enhancing the impact of hospital care for all 
acute conditions.
EECC in the COVID-19 pandemic
EECC has added importance in a situation causing a 
substantial amount of severe disease and the Delphi 
panel agreed that EECC should be part of the care 
of critically ill patients with COVID-19. In addition, 
the agreed essential diagnostic- specific care for 
COVID-19 can assist in decisions about the priorities 
of care when the pandemic threatens to overwhelm 
available resources. All of the COVID-19 specific 
processes are well established and are included in 
the WHO COVID-19 clinical management guid-
ance.30 The WHO guidance, and others,54 addi-
tionally include recommendations for advanced 
critical care (such as mechanical ventilation, vaso-
pressors and extracorporeal oxygenation), which 
may be difficult to rapidly scale- up in settings of 
low resources. Advanced critical care can be neces-
sary to save the lives of some patients, but has a 
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Table 3 The hospital readiness requirements for Essential Emergency and Critical Care
Identification of critical illness
The following items are required for a hospital to be ready for the identification of critically ill patients
Category Item
  1.1. Equipment 1.1.1 Clock with secondhand
1.1.2 Pulse oximeter and probe
1.1.3 Blood pressure measuring equipment (eg, sphygmomanometer with a stethoscope)
1.1.4 Blood pressure cuffs of different paediatric and adult sizes
1.1.5 Light source (lamp or flashlight)
1.1.6 Thermometer
  1.2 Consumables 1.2.1 Soap or hand disinfectant
1.2.2 Examination gloves
  1.3 Drugs       None
  1.4 Human 
resources
1.4.1 Health workers with the ability to identify critical illness 24 hours/day
  1.5 Training 1.5.1 The health workers are trained in the identification of critical illness
  1.6 Routines 1.6.1 Routines for the identification of critical illness
  1.7 Guidelines 1.7.1 Guidelines for the identification of critical illness
  1.8 Infrastructure 1.8.1  Designated triage area (area for the identification of critical illness) in the Out- Patient Department or 
Emergency Unit (area of the hospital where patients arrive)
1.8.2 Running water
Care of critical illness
The following items are required for a hospital to be ready to provide the care of critically ill patients
  2.1 Equipment 2.1.1 Suction machine (electric or manual)
2.1.3 Oxygen supply 24 hours/day (cylinder, concentrator (with electricity supply) or piped oxygen)
2.1.4 Flow meter (if using cylinder or piped oxygen)
2.1.5 Leak- free connectors from oxygen source to tubing
2.1.6 Bag valve mask (resuscitator)—neonatal, paediatric and adult sizes
2.1.7 Sharps disposal container
2.1.8 External heat source
  2.2 Consumables 2.2.1 Suction catheters of paediatric and adult sizes
2.2.2 Guedel airways of paediatric and adult sizes
2.2.3 Pillows
2.2.4 Oxygen tubing
2.2.5 Oxygen nasal prongs
2.2.6 Oxygen face masks of paediatric and adult sizes
2.2.7 Oxygen face masks with reservoir bags of paediatric and adult sizes
2.2.8 Masks for bag valve mask (resuscitator)—neonatal, paediatric and adult sizes
2.2.9 Compression bandages
2.2.10 Plasters or tape
2.2.11 Gauze
2.2.12 Intravenous cannulas of paediatric and adult sizes
2.2.13 Intravenous giving sets




2.2.18 Lubricant for nasogastric tube insertion
2.2.19 Intramuscular needles
2.2.20 Intraosseous cannulas of different sizes
2.2.21 Blankets
2.2.22 Facemasks for infection prevention and control
2.2.23 Aprons or gowns
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high cost per recovery and risks diverting scarce 
resources to a few individuals.55–60 Fortunately, the 
focus has shifted in the global pandemic response 
from advanced critical care towards securing basic 
oxygen delivery systems61 62 underscored by state-
ments from the WHO and other partners.63 64 The 
impact of this shift, in and beyond the pandemic, 
could be even greater if the necessary processes for 
  2.3 Drugs 2.3.1 Oral rehydration solution
2.3.2 Intravenous crystalloid fluids (eg, normal saline or Ringer’s Lactate)







2.3.10 Local anaesthetic (eg, 2% lignocaine) (eg, for intraosseous cannulation)
  2.4 Human 
resources
2.4.1 Health workers with the ability to care for critically ill patients 24 hours/day
2.4.2 Senior health worker who can be called to assist with the care of critically ill patients 24 hour/day
  2.5 Training 2.5.1 The health workers are trained in the care of critically ill patients
  2.6 Routines 2.6.1 Routines for managing critically ill patients
2.6.2 Routine for the provision of EECC without taking into account patients’ ability to pay
2.6.3 Routines for who and how to call to seek senior help 24 hours/day, 7 days/week
2.6.4  Routines for integrating EECC with other care including the definitive care of the underlying 
condition (eg, use of condition- specific guidelines)
  2.7 Guidelines 2.7.1 Guidelines for the essential care of critically ill patients
  2.8 Infrastructure 2.8.1 Designated space for the care of critically ill patients (eg, a bay, ward, high dependency unit)
2.8.2  Areas for separating and managing patients with a suspected or confirmed contagious disease from 
those without
Table 3 Continued
Table 4 The essential diagnosis- specific care for critically ill patients with COVID-19
Clinical processes
1. The Essential Emergency and Critical Care (EECC) clinical processes as specified for all critical illnesses
2. Personal protective equipment (PPE) that is appropriate for COVID-19 as part of infection, prevention and control
3. Monitoring oxygen saturation using pulse oximetry at least every 6 hours, unless otherwise prescribed
4. Intermittent prone positioning
5. Low molecular weight heparin or other anticoagulant
6. Corticosteroid
7. Antibiotics in patients with suspected bacterial superinfection
Hospital readiness requirements
Critically ill patients with COVID-19 require the same hospital readiness for EECC as other critically ill patients. For the 
provision of the essential diagnosis specific care of critically ill patients with COVID-19, the following additional items are 
required
Category Item
3.1 Equipment   None
3.2 Consumables 3.2.1 Facemasks appropriate for COVID-19 (eg, N95)
3.2.2 Eye protection or face shields
3.3 Drugs 3.3.1 Low- molecular weight heparin (eg, enoxaparin or dalteparin) or other anticoagulant
3.3.2 Corticosteroid (eg, dexamethasone)
3.4 Human resource 3.4.1 Health workers with the ability to care for critically ill patients with COVID-19 24 hours/day
3.5 Training 3.5.1 The health workers are trained in essential care of critically ill patients with COVID-19
3.6 Routines 3.6.1 Routines for care of critically ill patients with COVID-19
3.7 Guidelines 3.7.1 Guidelines for essential care of critically ill patients with COVID-19
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the effective use of oxygen and other care specified 
in EECC were included in the scale- up.
Strengths and limitations
Our use of a consensus method with a large expert 
panel from diverse clinical and resource settings, 
specialties and geographical locations gives the spec-
ified content legitimacy. The high response rate for 
this type of study during an ongoing pandemic illus-
trates the interest that experts had in the project’s 
aims. The high level of consensus (>90%) for the 
included clinical processes promotes confidence 
in the final package. However, the Delphi method 
does have limitations. It is expert- opinion based 
and is limited by the make- up of the panel. Only 
English language speakers were included, experts 
were not included from all countries and the expe-
dited timeline of the project due to the need for 
results that could impact the global response to the 
COVID-19 pandemic may have excluded experts 
who could have provided additional input. The 
initial content presented to the panel was aligned 
with WHO initiatives,39 and developed by a diverse 
specialist team, but the possibility remains that 
alternative methods would have led to a different 
output. The study did not address the underlying 
evidence- base for the included clinical processes, 
the impact, or the potential opportunity costs of 
increasing the coverage of EECC in hospitals—
such system- wide effects warrant careful evaluation 
during EECC implementation. It should be noted 
that, while policy makers were involved throughout 
the process, the EECC content has not been ratified 
by the WHO or governmental ministries of health—
the method has been primarily scientific. The find-
ings should be seen as the first version of the EECC 
content, as recommended by global clinicians and 
researchers, one that could be incorporated into 
WHO and other global and national programmes 
and that should subsequently be improved and 
updated as new knowledge arises.
Implications
Implementation of EECC could be an effective 
strategy as part of the current calls to save lives through 
improved quality of care in health systems65—a ‘low- 
hanging fruit’. Critically ill patients have high mortality 
rates in all hospital settings, especially where trained 
staff or resources are limited, and even small improve-
ments in outcomes would have a large impact. EECC 
has a vital role in the ongoing COVID-19 pandemic, 
for the care of the surge of critically ill patients and 
for optimising the impact of the efforts to scale- up 
oxygen. Policy makers at global, national and regional 
levels aiming to reduce preventable deaths should 
focus on improved coverage of EECC and inclusion 
of EECC as part of universal health coverage.36
CONCLUSION
The content of EECC—and the essential care of crit-
ically ill patients with COVID-19—has been speci-
fied using an inclusive global consensus. The content 
consists of effective, low- cost and low- complexity life- 
saving care that is still frequently overlooked. The time 
has come to ensure that all patients in the world receive 
this care.
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